- General Population Risk is 2.5 – 3% risk
- Increases with age, greater than 60 is at 10-20% risk
- Other risk factors: Emergency surgery, complex surgery, femur fracture
- 30-day mortality increases if post op delirium is present by 7-10%
- Increase risk for functional decline as well.
- Increase cost by 2k-8k per case
Theories:
- Neuroinflammation with increased neuromediations such as CRP, IL6
- Neurotransmitters some research showing lower Ach activity
- Subclinical CVAs with studies showing 7-10% radiological evidence without signs or symptoms of CVAs
Mangement:
- Most ideal is itenfidying high risk and reducing the risk
- Pre-op:
- Avoid polypharmacy which is an independent risk factor
- Avoid prolong fluid (>6h) fasting
- Multi-disciplinary team with complex geriatric assessment
- Pre-op pain control
- Intra Operative
- Depth of anesthesia
- Consider BIS
- Multimodal Opioid Sparing Analgesia
- Increased post op pain increased risk for delirium
- Use of opioids increase risk
- Utilize regional or neuraxial when appropriate
- NSAIDS
- Decreased pain and inflammation including the theorized neuroinflammation
- Dexmedetomidine
- Neuroprotective in animal studies with decreased inflammatory markers (cortisol, CRP, TNF alpha)
- Improves sleep disturbances (associated with delirium)
- 18 clinical trials showing decreased delirium
- Other Perioperative medications
- Increased delirium with TCA, antihistamines, benzodiazepines, scopolamine, gabapentin
- Some evidence showing subhyptnoic dose ketamine could improve post op delirium
- Dexamethasone decreases inflammation
- Melatonin
- Choice of General
- Volatile has been theorized to exacerbate neuroinflmamation however observational studies haven’t demonstrated vs IV medications
- Xenon showed neuro protective in animal studies
- Fluids
- Goal directed fluid therapy
- Blood products can worsen due to systemic inflammation
- Depth of anesthesia
- Post O
- Nonpharm
- Re-orientation, natural light, time keeping indicators (clocks, date)
- Pharm
- Antipyschotics
- Some data supporting dopamine antagonists could improve use more as a rescue. Second generation better tolerated than first generation
- Avoid Benzodiazepines which was the prior first line rescue treatment
- Antipyschotics
- Nonpharm